HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking

AIDS Reviews

Volumn 10, Issue 4, 2008, Pages 195-204

  Baydoun, Hicham H ^a   Bellon, Marcia ^a   Nicot, Christophe ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

HTLV 1; p30; Posttranscriptional regulation; Rex; RNA export

Indexed keywords

MESSENGER RNA; PROTEIN P30; REX PROTEIN; TAX PROTEIN; VIRUS RNA;

GENE EXPRESSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; REGULATORY MECHANISM; REVIEW; RNA PROCESSING; RNA SPLICING; RNA TRANSPORT; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRAL GENETICS; VIRUS LATENCY; VIRUS PARTICLE; VIRUS REPLICATION;

GENE EXPRESSION REGULATION; GENE PRODUCTS, REX; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 59549094794     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-92.
2. Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes cytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415-19.
3. Poiesz B, Ruscetti F, Mier J, Woods A, Gallo R. T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc Natl Acad Sci USA. 1980;77:6815-19.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79:2031-5.
5. Bazarbachi A, Ghez D, Lepelletier Y, et al. New therapeutic approaches for adult T-cell leukemia. Lancet Oncol. 2004;5:664-72.
6. Gessain A, Barin F, Vernant J, et al. Antibodies to HTLV-1 in patients with tropical spastic paraparesis. Lancet. 1985;2:407-10.
7. Osame M, Usuku K, Izumo S, et al. HTLV-1 associated myelopathy, a new clinical entity. Lancet. 1986;1:1031-2.
8. Nicot C. Current views in HTLV-1-associated adult T-cell leukemia/ lymphoma. Am J Hematol. 2005;78:232-9.
9. Franchini G, Nicot C, Johnson J. Seizing of T-cells by HTLV-1. Adv Cancer Res. 2003;89:69-132.
10. Bangham C, Osame M. Cellular immune response to HTLV-1. Oncogene. 2005;24:6035-46.
11. Takenouchi N, Yao K, Jacobson S. Immunopathogenesis of HTLV-1 associated neurologic disease: molecular, histopathologic, and immunologic approaches. Front Biosci. 2004;9:2527-39.
12. Koralnik I, Gessain A, Klotman M, Lo M, Berneman Z, Franchini G. Protein isoforms encoded by the pX region of HTLV-1. Proc Natl Acad Sci USA. 1992;89:8813-17.
13. Ciminale V, Pavlakis G, Derse D, Cunningham C, Felber B. Complex splicing in the HTLV family of retroviruses: novel mRNAs and proteins produced by HTLV-1. J Virol. 1992;66:1737-45.
14. Gitlin S, Dittmer J, Shin R, Brady J. Transcriptional activation of the HTLV-1 long terminal repeat by functional interaction of Tax1 and Ets1. J Virol. 1993;67:7307-16.
15. Kashanchi F, Brady J. Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene. 2005;24:5938-51.
16. Younis I. Green P. The HTLV Rex protein. Front Biosci. 2005;10:431-45.
17. Mesnard J, Barbeau B, Devaux C. HBZ, a new important player in the mys tery of adult T-cell leukemia. Blood. 2006;108:3979-82.
18. Jeong S, Lu H, Cho W, Park H, Pise-Masison C, Brady J. Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the HTLV-1 long terminal repeat through direct interaction with Tax. J Virol. 2006;80:10036-44.
19. Siu Y, Chin K, Siu K, Yee Wai C, Jeang K, Jin D. TORC1 and TORC2 co-activators are required for tax activation of the HTLV-1 long terminal repeats. J Virol. 2006;80:7052-9.
20. Koga H, Ohshima T, Shimotohno K. Enhanced activation of tax-dependent transcription of HTLV-1 long terminal repeat by TORC3. J Biol Chem. 2004;279:52978-83.
21. Jiang H, Lu H, Schiltz R, et al. PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol Cell Biol. 1999;19:8136-45.
22. Harrod R, Tang Y, Nicot C, et al. An exposed KID-like domain in HTLV-1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol Cell Biol. 1998;18:5052-61.
23. Giebler H, Loring J, Van Orden K, et al. Anchoring of CREB binding protein to the HTLV-1 promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol. 1997;17:5156-64.
24. Taylor J, Nicot C. HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis. 2008;13:733-47.
25. Gatza M, Watt J, Marriott S. Cellular transformation by the HTLV-1 Tax protein, a jack-of-all-trades. Oncogene. 2003;22:5141-9.
26. Yamada Y, Kamihira S. Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma. Leuk Lymphoma. 2005;46:1553-9.
27. Marriott S, Semmes O. Impact of HTLV-1 Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene. 2005;24: 5986-95.
28. Bellon M, Nicot C. Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst. 2008;100:98-108.
29. Seiki M, Inoue J, Hidaka M, Yoshida M. Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of HTLV-1. Proc Natl Acad Sci USA. 1988;85:7124-8.
30. Wen W, Meinkoth J, Tsien R, Taylor S. Identification of a signal for rapid export of proteins from the nucleus. Cell. 1995;82:463-73.
31. Bogerd H, Fridell R, Benson R, Hua J, Cullen B. Protein sequence requirements for function of the HTLV-1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol Cell Biol. 1996;16:4207-14.
32. Kim F, Beeche A, Hunter J, Chin D, Hope T. Characterization of the nuclear export signal of HTLV-1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions. Mol Cell Biol. 1996;16:5147-55.
33. Palmeri D, Malim M. The HTLV-1 posttranscriptional trans-activator Rex con tains a nuclear export signal. J Virol. 1996;70:6442-5.
34. Ossareh-Nazari B, Bachelerie F, Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science. 1997;278:141-4.
35. Fornerod M, Ohno M, Yoshida M, Mattaj I. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 1997;90:1051-60.
36. Stade K, Ford C, Guthrie C, Weis K. Exportin 1 (Crm1p) is an essential nu clear export factor. Cell. 1997;90:1041-50.
37. Bischoff F, Ponstingl H. Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1. Nature. 1991;354:80-2.
38. Hakata Y, Umemoto T, Matsushita S, Shida H. Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of HTLV-1. J Virol. 1998;72:6602-7.
39. Englmeier L, Fornerod M, Bischoff F, Petosa C, Mattaj I, Kutay U. RanBP3 influences interactions between CRM1 and its nuclear protein export substrates. EMBO Rep. 2001;2:926-32.
40. Malim M, Cullen B. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell. 1991;65:241-8.
41. Bogerd H, Greene W. Dominant negative mutants of HTLV-1 Rex and HIV-1 Rev fail to multimerize in vivo. J Virol. 1993;67:2496-502.
42. Heger P, Rosorius O, Koch C, Casari G, Grassmann R, Hauber J. Multimer formation is not essential for nuclear export of HTLV-1 Rex transactivator protein. J Virol. 1998;72:8659-68.
43. Koya Y, Ohashi T, Kato H, et al. Establishment of a seronegative HTLV-1 carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax. J Virol. 1999;73:6436-43.
44. Hakata Y, Yamada M, Shida H. Rat CRM1 is responsible for the poor activity of HTLV-1 Rex protein in rat cells. J Virol. 2001;75:11515-25.
45. Takayanagi R, Ohashi T, Yamashita E, et al. Enhanced replication of HTLV-1 in T-cells from transgenic rats expressing human CRM1 that is regulated in a natural manner. J Virol. 2007;81:5908-18.
46. Hakata Y, Yamada M, Shida H. A multifunctional domain in human CRM1 (exportin 1) mediates RanBP3 binding and multimerization of HTLV-1 Rex protein. Mol Cell Biol. 2003;23:8751-61.
47. Katahira J, Ishizaki T, Sakai H, Adachi A, Yamamoto K, Shida H. Effects of translation initiation factor eIF-5A on the functioning of HTLV-1 Rex and HIV Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding. J Virol. 1995;69:3125-33.
48. Grone M, Hoffmann E, Berchtold S, Cullen R, Grassmann R. A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo. Virology. 1994;204:144-52.
49. Hanly S, Rimsky L, Malim M, et al. Comparative analysis of the HTLV-1 Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev. 1989;3:1534-44.
50. Ahmed Y, Hanly S, Malim M, Cullen B, Greene W. Structure-function ana lyses of the HTLV-1 Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action. Genes Dev. 1990;4:1014-22.
51. Bogerd H, Huckaby G, Ahmed Y, Hanly S, Greene W. The HTLV-1 Rex transactivator binds directly to the HTLV-1 Rex and the HIV-1 Rev RNA response elements. Proc Natl Acad Sci USA. 1991;88:5704-8.
52. Bogerd H, Tiley L, Cullen B. Specific binding of the HTLV-1 Rex protein to a short RNA sequence located within the Rex-response element. J Virol. 1992;66:7572-5.
53. Rimsky L, Hauber J, Dukovich M, et al. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature. 1988;335:738-40.
54. Unge T, Solomin L, Mellini M, Derse D, Felber B, Pavlakis G. The Rex regulatory protein of HTLV-1 binds specifically to its target site within the viral RNA. Proc Natl Acad Sci USA. 1991;88:7145-49.
55. Rimsky L, Dodon M, Dixon E, Greene W. Trans-dominant inactivation of HTLV-1 and HIV-1 gene expression by mutation of the HTLV-1 Rex transactivator. Nature. 1989;341:453-6.
56. Solomin L, Felber B, Pavlakis G. Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of HIV-1. J Virol. 1990;64:6010-17.
57. Dodon M, Hamaia S, Martin J, Gazzolo L. Heterogeneous nuclear ribonucleoprotein A1 interferes with the binding of the HTLV-1 rex regulatory protein to its response element. J Biol Chem. 2002; 277:18744-52.
58. Ahmed Y, Gilmartin G, Hanly S, Nevins J, Greene W. The HTLV-1 Rex response element mediates a novel form of mRNA polyadenylation. Cell. 1991;64:727-37.
59. Siomi H, Shida H, Nam S, Nosaka T, Maki M, Hatanaka M. Sequence requirements for nucleolar localization of HTLV-1 pX protein, which regulates viral RNA processing. Cell. 1988;55:197-209.
60. Adachi Y, Copeland T, Hatanaka M, Oroszlan S. Nucleolar targeting signal of Rex protein of HTLV-1 specifically binds to nucleolar shuttle protein B-23. J Biol Chem. 1993;268;13930-4.
61. Sinha-Datta U, Datta A, Ghorbel S, Dodon M, and Nicot C. HTLV-1 rex and p30 interactions govern the switch between virus latency and replication. J Biol Chem. 2007;282:14608-15.
62. Grone M, Koch C, Grassmann R. The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation. Virology. 1996;218:316-25.
63. Adachi Y, Nosaka T, Hatanaka M. Protein kinase inhibitor H-7 blocks ac cumulation of unspliced mRNA of HTLV-1. Biochem Biophys Res Commun. 1990;169:469-75.
64. Adachi Y, Copeland T, Takahashi C, et al. Phosphorylation of the Rex protein of HTLV-1. J Biol Chem. 1992;267:21977-81.
65. McGuire K, Curtiss V, Larson E, Haseltine W. Influence of HTLV-1 tax and rex on IL-2 gene expression. J Virol. 1993;67:1590-9.
66. Kanamori H, Suzuki N, Siomi H, et al. HTLV-1 p27rex stabilizes human IL-2 receptor-α chain mRNA. EMBO J. 1990;9:4161-6.
67. White K, Nosaka T, Kanamori H, Hatanaka M, Honjo T. The nucleolar localization signal of the HTLV-1 protein p27rex is important for stabilization of IL-2 receptor-α subunit mRNA by p27rex. Biochem Biophys Res Commun. 1991;175:98-103.
68. Kanamori H, Kodama T, Yazaki Y. The 5′ coding sequence of IL-2 receptor-α chain mRNA mediates mRNA stabilization by HTLV-1 Rex. Immunology. 1995;86:551-5.
69. Weil R, Levraud J, Dodon M, et al. Altered expression of tyrosine kinases of the Src and Syk families in HTLV-1-infected T-cell lines. J Virol. 1999;73:3709-17.
70. Cooke M, Abraham K, Forbush K, Perlmutter R. Regulation of T-cell receptor signaling by a src family protein-tyrosine kinase (p59fyn). Cell. 1991;65:281-91.
71. Valentin H, Hamaia S, Konig S, Gazzolo L. Vascular cell adhesion molecule-1 induced by HTLV-1 Tax protein in T-cells stimulates proliferation of human T-lymphocytes. J Gen Virol. 2001;82:831-5.
72. Nicot C, Dundr M, Johnson J. et al. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med. 2004;10:197-201.
73. Albrecht B, Lairmore M. Critical role of HTLV-1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev. 2002;66:396-406.
74. Nicot C, Harrod R, Ciminale V, Franchini G. HTLV-1 nonstructural genes and their functions. Oncogene. 2005;24:6026-34.
75. D'Agostino D, Silic-Benussi M, Hiraragi H, Lairmore M, Ciminale V. The HTLV-1 p13II protein: effects on mitochondrial function and cell growth. Cell Death Differ. 2005;12(Suppl 1):905-15.
76. Derse D, Mikovits J, Ruscetti F. X-I and X-II open reading frames of HTLV-1 are not required for virus replication or for immortalization of primary T-cells in vitro. Virology. 1997;237:123-8.
77. Robek M, Wong F, Ratner L. HTLV-1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol. 1998;72:4458-62.
78. Princler G, Julias J, Hughes S, Derse D. Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology. 2003;317:136-45.
79. Cereseto A, Berneman Z, Koralnik I, Vaughn J, Franchini G, Klotman M. Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines. Leukemia. 1997;11:866-70.
80. Berneman Z, Gartenhaus R, Reitz M, et al. Expression of alternatively spliced HTLV-1 pX mRNA in infected cell lines and in primary uncultured cells from patients with ATLL and healthy carriers. Proc Natl Acad Sci USA. 1992;89:3005-9.
81. Dekaban G, Peters A, Mulloy J, et al. The HTLV-1 orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits. Virology. 2000;274:86-93.
82. Pique C, Ureta-Vidal A, Gessain A, et al. Evidence for the chronic in vivo production of HTLV-1 Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med. 2000;191:567-72.
83. Hiraragi H, Kim S, Phipps A, et al. HTLV-1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J Virol. 2006;80:3469-76.
84. Silverman L, Phipps A, Montgomery A, Ratner L, Lairmore M. HTLV-1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol. 2004;78:3837-45.
85. Lairmore M, Albrecht B, D'Souza C, et al. In vitro and in vivo functional analysis of HTLV-1 pX open reading frames I and II. AIDS Res Hum Retroviruses. 2000;16:1757-64.
86. Bartoe J, Albrecht B, Collins N, et al. Functional role of pX open reading frame II of HTLV-1 in maintenance of viral loads in vivo. J Virol. 2000;74:1094-100.
87. Collins N, Newbound G, Albrecht B, Beard J, Ratner L, Lairmore M. Selective ablation of HTLV-1 p12I reduces viral infectivity in vivo. Blood. 1998;91:4701-7.
88. Michael B, Nair A, Hiraragi H, et al. HTLV-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology. 2004;1:39.
89. Younis I, Khair L, Dundr M, Lairmore M, Franchini G, Green P. Repression of HTLV type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol. 2004;78:11077-83.
90. Dundr M, Misteli T. Functional architecture in the cell nucleus. Biochem J. 2001;356:297-310.
91. Moroianu J, Riordan J. Identification of the nucleolar targeting signal of human angiogenin. Biochem Biophys Res Commun. 1994;203:1765-72.
92. Creancier L, Prats H, Zanibellato C, Amalric F, Bugler B. Determination of the functional domains involved in nucleolar targeting of nucleolin. Mol Biol Cell. 1993;4:1239-50.
93. Ghorbel S, Sinha-Datta U, Dundr M, Brown M, Franchini G, Nicot C. HTLV-1 p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J Biol Chem. 2006;281:37150-8.
94. Boisvert F, van Koningsbruggen S, Navascues J, Lamond A. The multifunctional nucleolus. Nat Rev Mol Cell Biol. 2007;8:574-85.
95. Hiscox J. RNA viruses: hijacking the dynamic nucleolus. Nat Rev Microbiol. 2007;5:119-27.
96. Hiscox J. The nucleolus-a gateway to viral infection? Arch Virol. 2002;147:1077-89.
97. Dhar D, Mapa K, Pudi R, Srinivasan P, Bodhinathan K, Das S. Human ribosomal protein L18a interacts with HCV internal ribosome entry site. Arch Virol. 2006;151:509-24.
98. Ji H, Fraser C, Yu Y, Leary J, Doudna J. Coordinated assembly of human translation initiation complexes by the HCV internal ribosome entry site RNA. Proc Natl Acad Sci USA. 2004;101:16990-5.
99. Haas M, Geldreich A, Bureau M, et al. The open reading frame VI product of Cauliflower mosaic virus is a nucleocytoplasmic protein: its N terminus mediates its nuclear export and formation of electron-dense viroplasms. Plant Cell. 2005;17:927-43.
100. Bureau M, Leh V, Haas M, et al. P6 protein of Cauliflower mosaic virus, a translation reinitiator, interacts with ribosomal protein L13 from Arabidopsis thaliana. J Gen Virol. 2004;85;3765-75.
101. Leh V, Yot P, Keller M. The cauliflower mosaic virus translational transactivator interacts with the 60S ribosomal subunit protein L18 of Arabidopsis thaliana. Virology. 2000;266:1-7.
102. Dundr M, Leno G, Hammarskjold M, et al. The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. J Cell Sci. 1995;108:2811-23.
103. Kubota S, Hatanaka M, Pomerantz R. Nucleocytoplasmic redistribution of the HTLV-1 Rex protein: alterations by co-expression of the HTLV-1 p21x protein. Virology. 1996;220:502-7.